NCT00529984 A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT00529113 Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT00524069 Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery Status WITHDRAWN Phase NA
NCT00521404 Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00511264 Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract Status COMPLETED Phase N/A
NCT00504998 Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00499486 Sirolimus in Treating Patients With Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00499265 Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00498225 Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT00493441 AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00490373 Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic Status COMPLETED Phase PHASE2
NCT00489671 Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis Status COMPLETED Phase N/A
NCT00489515 Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder Status COMPLETED Phase N/A
NCT00486460 Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer Status UNKNOWN Phase PHASE3
NCT00478010 Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer Status COMPLETED Phase NA
NCT00470535 Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00467116 PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca Status COMPLETED Phase PHASE1